Exploring breast cancer treatment paradigms: innovative design, molecular docking and dynamic simulation of LOXL2 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploring breast cancer treatment paradigms: innovative design, molecular docking and dynamic simulation of LOXL2 inhibitors

Published:2024-03-31 Issue:10 Volume:50 Page:631-643
ISSN:0892-7022
Container-title:Molecular Simulation
language:en
Short-container-title:Molecular Simulation

Author:

Baothman Othman A.¹²^ORCID,Islam Md Rashedul¹³^ORCID

Affiliation:

1. Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

2. Centre for Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah, Saudi Arabia

3. Advanced Biological Invention Centre (Bioinventics), Rajshahi, Bangladesh

Funder

Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08927022.2024.2333907

Reference52 articles.

1. Breast Cancer Statistics, 2022

2. LOXL2 Inhibitors and Breast Cancer Progression

3. Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: changes in the expression of LOXL during development and growth of mouse tissues

4. The rationale for targeting the LOX family in cancer

5. Lysyl Oxidase: Its Diversity in Health and Diseases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP